Home › Products › Pulmonology › Survanta 200mg Injection

Survanta 200mg Injection

Salt Composition: BERACTANT

₹16605.00₹17479.47

Inclusive of all taxes

Categories: Pulmonology

Conditions: Respiratory Disorder

Product Introduction

Survanta 200mg injection contains beractant, a pulmonary surfactant extracted from bovine lungs. It is indicated for the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature newborns with a birth weight of 700g or more. The injection is also used in premature infants born before 32 weeks of gestation who are at risk of RDS and require endotracheal intubation for stabilisation. RDS occurs when the lungs of premature infants are insufficiently developed, resulting in breathing difficulties.

Do not use Survanta 200mg injection if patients are allergic to beractant or any ingredient in the formulation. Seek immediate medical attention if serious ocular symptoms or cardiac complications develop during treatment. Common adverse effects include noisy breathing, feeding difficulties, gastrointestinal disturbances, and bleeding around the endotracheal tube.

Uses

Survanta 200mg injection uses include: Preventing and treating Respiratory Distress Syndrome (RDS) in premature newborns.

How it works

Survanta 200mg injection works by providing a substance called surfactant to the baby's lungs. This surfactant helps the lungs work better by reducing the tension on the surfaces of the air sacs. The survanta 8ml inj also helps keep the air sacs open and prevents them from collapsing during breathing. This makes it easier for the baby to breathe and improves their lung function.

Side Effects

Survanta injection side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them. survanta side effects include: Serious side effects of Survanta 200mg Injection are: Pale skin Slow heartbeat Breathing that stops Urinating less than usual Blood in the urine Common side effects of Survanta 200mg Injection are: Noisy breathing Feeding or bowel problems Bleeding around the endotracheal tube.

References

  1. Abbvie Ltd; Electronic Medicines Compendium (EMC); [Revised on June 2020] [Accessed on 24th July 2023], pil.834.pdf (medicines.org.uk)
  2. AbbVie Inc; US Food and Drug Administration; [Revised on December 2019] [Accessed on 24th July 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/020032s045lbl.pdf
  3. AbbVie corporation; Survanta; Patient medication information; [Revised on 04th June 2021] [Accessed on 24th July 2023], https://www.abbvie.ca/content/dam/abbvie-dotcom/ca/en/documents/products/SURVANTA_PM_EN.pdf

Safety Advice

Pregnancy: unsafe Survanta 200mg injection is not indicated for women of childbearing age and should not be used during pregnancy. If you are pregnant or planning to become pregnant, discuss the potential risks and benefits of the medication with your healthcare provider.

Lungs: Consult your doctor It is unknown whether Survanta 200mg injection is safe for patients with lung problems. Inform your physician if you have any lung disease before starting the treatment. Contact your doctor if you experience any lung-related symptoms.

Breastfeeding: unsafe Survanta 200mg injection is not indicated for women and should not be used during breastfeeding. Consult your doctor for more information.

Disclaimer

The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.

Written By: Muskan Patel, M.Pharm

Reviewed By: Dr. Vishwa Patel, MBBS